CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Enric I. Canela

OPENALEX: A5037871513↗ORCID: 0000-0003-4992-7440↗

Affiliations

Organizations

Biomedical Research Networking Center on Neurodegenerative Diseasesauthorship · ES Centro de Investigación Biomédica en Redauthorship · ES Institut de Biomedicina de la Universitat de Barcelonaauthorship Institute for Research in Biomedicineauthorship · ES Instituto de Salud Carlos IIIauthorship · ES Universitat de Barcelonaauthorship · ES

Public evidence

5 connected articles

The CB<sub>1</sub> receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls.2024 · Europe PMC Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.2021 · PubMed Central Open Access Cannabigerol Action at Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptors and at CB<sub>1</sub>-CB<sub>2</sub> Heteroreceptor Complexes.2018 · Europe PMC Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB<sub>2</sub> Receptors.2017 · Europe PMC Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors2015 · PubMed Central Open Access

Registered research

Connected studies

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adultsnct05743985

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Enric I. Canela - Medical Cannabis Research Engine